Is the Double Dose Alpha-Blocker Treatment Superior Than the Single Dose in the Management Of Patients Suffering From Acute Urinary Retention Caused By Benign Prostatic Hyperplasia?

KARA Ö., Yazici M.

UROLOGY JOURNAL, vol.11, no.3, pp.1673-1677, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 3
  • Publication Date: 2014
  • Journal Name: UROLOGY JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1673-1677
  • Keywords: acute disease, administration, oral, prostatic hyperplasia, drug therapy, treatment outcome, urinary retention, adrenergic alpha-1 receptor antagonists, NATURAL-HISTORY, RISK-FACTORS, ALFUZOSIN, CATHETER, PLACEBO, TRIAL, BPH, TAMSULOSIN, EFFICACY, SAFETY
  • Ankara University Affiliated: Yes

Abstract

Purpose: To compare the efficacy and safety of single (tamsulosin) and double dose (tamsulosin + alfuzosin) alpha-blocker therapy for treating catheterized patients with acute urinary retention (AUR) due to benign prostatic hyperplasia (BPH).